Deschatelets Pascal
SEC insider (Form 3/4/5 filer). CIK 0001657720. Chief Scientific Officer at Apellis Pharmaceuticals, Inc. (APLS). 24 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in WALTHAM, MA.
Companies Deschatelets Pascal has filed insider reports for
- Apellis Pharmaceuticals, Inc. (APLS): Officer, Chief Scientific Officer
Deschatelets Pascal
CIK: 0001657720
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Apellis Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferDirect1.2M shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect41.3K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect41.3K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect10K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect10K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect12.9K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect12.9K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect25.8K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect25.8K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect4.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 1,177,222 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 41,250 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 41,250 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 10,030 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 10,030 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 12,920 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 12,920 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 25,840 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 25,840 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 4,909 | - | $0 | Direct |
1-10 of 24 transactions